Sarepta Therapeutics, Inc. Annual Interest Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2015 to 2024.
  • Sarepta Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2024 was -$32.3M, a 16.7% increase year-over-year.
  • Sarepta Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2024 was -$18.4M, a 16.4% increase year-over-year.
  • Sarepta Therapeutics, Inc. annual Interest Expense for 2024 was -$18.4M, a 16.4% increase from 2023.
  • Sarepta Therapeutics, Inc. annual Interest Expense for 2023 was -$22M, a 58.7% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Interest Expense for 2022 was -$53.2M, a 184% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$18.4M +$3.62M +16.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 -$22M +$31.2M +58.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$53.2M -$117M -184% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $63.5M +$3.58M +5.97% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $59.9M +$29.3M +95.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $30.7M -$3.04M -9.02% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $33.7M +$27.9M +481% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $5.8M +$3.91M +207% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $1.89M +$527K +38.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.37M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.